Allergy Therapeutics appoints interim CFO
![Photo: Liz Hafalia/AP/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/14610055/94mdx9/ALTERNATES/schema-16_9/22262563247233-1620x913ma.jpg)
Allergy Therapeutics has hired a new, interim chief financial officer after Nick Wykeman, who spent six years serving the company, announced in May his departure on Nov. 30.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
ALK raises minimum full-year sales guidance after Q3
For subscribers